Bottom line
BBH vs FBT: the short answer
BBH (VanEck Biotech ETF) and FBT (First Trust NYSE Arca Biotechnology Index Fund) are quite different portfolios: only about 36% of their top holdings (by weight) are shared.
BBH is cheaper at 0.35% vs 0.55% — a difference of $20 a year per $10,000 invested.
Over five years, FBT returned +4.3% a year vs +2.7% for BBH.
Updated Nov 19, 2026
BBH vs FBT side by side
| BBH | FBT | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | VanEck | First Trust |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.35% | 0.55% |
| Annual cost per $10k | $35 | $55 |
| 10-yr cost on $10k (prospectus) | $443 | — |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +21.2% | +24.1% |
| 5-yr return (annualized) | +2.7% | +4.3% |
| 10-yr return (annualized) | +4.5% | +6.3% |
| Best quarter | +27.6% | +27.8% |
| Worst quarter | −18.2% | −22.5% |
| Net assets (fund) | $395.6M | $2.8B |
| Number of holdings | 25 | 32 |
| Portfolio turnover | 19% | 37% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | BBH | FBT | Difference |
|---|---|---|---|
| 2025 | +21.2% | +24.1% | −2.9% |
| 2024 | −4.4% | +5.8% | −10.1% |
| 2023 | +3.9% | +2.3% | +1.6% |
| 2022 | −15.1% | −4.6% | −10.5% |
| 2021 | +11.8% | −3.6% | +15.4% |
| 2020 | +22.1% | +12.9% | +9.1% |
| 2019 | +25.8% | +19.8% | +6.0% |
| 2018 | −10.2% | −0.2% | −10.0% |
| 2017 | +16.6% | +37.0% | −20.4% |
| 2016 | −15.0% | −19.6% | +4.6% |
Source: Fund prospectus bar charts
Holdings overlap
13 of BBH's top 25 holdings also appear in FBT's top 25.
| Holding | BBH | FBT |
|---|---|---|
| Amgen Inc | 15.25% | 2.78% |
| Vertex Pharmaceuticals Inc | 9.10% | 3.07% |
| Argenx SE | 4.97% | 3.13% |
| Natera Inc | 4.92% | 3.79% |
| Alnylam Pharmaceuticals Inc | 3.83% | 2.52% |
| Biogen Inc | 3.63% | 3.37% |
| Illumina Inc | 3.17% | 3.92% |
| United Therapeutics Corp | 2.83% | 2.56% |
| Incyte Corp | 2.49% | 3.18% |
| Neurocrine Biosciences Inc | 2.08% | 3.53% |
| BioNTech SE | 1.94% | 2.63% |
| Bio-Techne Corp | 1.54% | 3.43% |
| BioMarin Pharmaceutical Inc | 1.34% | 2.83% |
Source: SEC Form N-PORT
BBH top 10
- Amgen Inc — 15.25%
- Gilead Sciences Inc — 12.79%
- Vertex Pharmaceuticals Inc — 9.10%
- Regeneron Pharmaceuticals Inc — 6.21%
- Revolution Medicines Inc — 5.27%
- Argenx SE — 4.97%
- Natera Inc — 4.92%
- IQVIA Holdings Inc — 4.31%
- Alnylam Pharmaceuticals Inc — 3.83%
- Biogen Inc — 3.63%
FBT top 10
- Corcept Therapeutics Inc — 5.60%
- Neogenomics Inc — 5.12%
- Veracyte Inc — 5.10%
- Bruker Corp — 4.32%
- Alkermes Plc — 4.24%
- Illumina Inc — 3.92%
- Krystal Biotech Inc — 3.87%
- Natera Inc — 3.79%
- Axsome Therapeutics Inc — 3.71%
- Neurocrine Biosciences Inc — 3.53%
FAQ
What is the difference between BBH and FBT?
Which is cheaper, BBH or FBT?
Should I own both BBH and FBT?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.